Michael S Roundy, PHYSICIAN SURGEON | |
630 Medical Dr, Bountiful, UT 84010-4908 | |
(801) 299-3781 | |
(201) 299-2416 |
Full Name | Michael S Roundy |
---|---|
Gender | Male |
Speciality | Psychiatry |
Experience | 32 Years |
Location | 630 Medical Dr, Bountiful, Utah |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1255366696 | NPI | - | NPPES |
260022408 | Other | RAILROAD MEDICARE | |
876000308007 | Medicaid | UT |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084P0800X | Psychiatry & Neurology - Psychiatry | 5349062 8905 (California) | Secondary |
2084P0800X | Psychiatry & Neurology - Psychiatry | 5349062-1205 (Utah) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Davis Behavioral Health Inc | 7416861919 | 44 |
Mountainstar Behavioral Health Llc | 1052558186 | 11 |
News Archive
MPI Research announced today that Thomas Laughlin will join the company as Executive Vice President of Sales and Marketing and will be a member of the company's Corporate Management Team. Laughlin's 30+ years of executive experience span several of the world's largest and most successful healthcare products companies.
"A new study suggests that most young gay men in Mexico City would pledge to stay HIV-free, attend a monthly safe-sex talk and take regular HIV tests to prove they were uninfected - all in return for just $288 a year," the New York Times reports.
Traumatic Axonal Injury is a form of traumatic brain injury that can have detrimental effects on the integrity of the brain's white matter and lead to cognitive impairments.
Gilead Sciences says its next generation drug to combat hepatitis C, slated to launch next month, will be more expensive than $1,000-a-pill Sovaldi, in part because the new treatment will be shorter and simpler. Gilead also struck a deal with Indian generic drugmakers to sell lower-cost versions of Sovaldi in poor countries.
Omeros Corporation today announced that its Investigational New Drug Application to evaluate OMS824 in Huntington's disease has been cleared by the U.S. Food and Drug Administration.
› Verified 5 days ago
Entity Name | Davis Behavioral Health Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1770641672 PECOS PAC ID: 7416861919 Enrollment ID: O20031118000909 |
News Archive
MPI Research announced today that Thomas Laughlin will join the company as Executive Vice President of Sales and Marketing and will be a member of the company's Corporate Management Team. Laughlin's 30+ years of executive experience span several of the world's largest and most successful healthcare products companies.
"A new study suggests that most young gay men in Mexico City would pledge to stay HIV-free, attend a monthly safe-sex talk and take regular HIV tests to prove they were uninfected - all in return for just $288 a year," the New York Times reports.
Traumatic Axonal Injury is a form of traumatic brain injury that can have detrimental effects on the integrity of the brain's white matter and lead to cognitive impairments.
Gilead Sciences says its next generation drug to combat hepatitis C, slated to launch next month, will be more expensive than $1,000-a-pill Sovaldi, in part because the new treatment will be shorter and simpler. Gilead also struck a deal with Indian generic drugmakers to sell lower-cost versions of Sovaldi in poor countries.
Omeros Corporation today announced that its Investigational New Drug Application to evaluate OMS824 in Huntington's disease has been cleared by the U.S. Food and Drug Administration.
› Verified 5 days ago
Entity Name | Mountainstar Behavioral Health Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1174868525 PECOS PAC ID: 1052558186 Enrollment ID: O20130605000270 |
News Archive
MPI Research announced today that Thomas Laughlin will join the company as Executive Vice President of Sales and Marketing and will be a member of the company's Corporate Management Team. Laughlin's 30+ years of executive experience span several of the world's largest and most successful healthcare products companies.
"A new study suggests that most young gay men in Mexico City would pledge to stay HIV-free, attend a monthly safe-sex talk and take regular HIV tests to prove they were uninfected - all in return for just $288 a year," the New York Times reports.
Traumatic Axonal Injury is a form of traumatic brain injury that can have detrimental effects on the integrity of the brain's white matter and lead to cognitive impairments.
Gilead Sciences says its next generation drug to combat hepatitis C, slated to launch next month, will be more expensive than $1,000-a-pill Sovaldi, in part because the new treatment will be shorter and simpler. Gilead also struck a deal with Indian generic drugmakers to sell lower-cost versions of Sovaldi in poor countries.
Omeros Corporation today announced that its Investigational New Drug Application to evaluate OMS824 in Huntington's disease has been cleared by the U.S. Food and Drug Administration.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Michael S Roundy, PHYSICIAN SURGEON 630 Medical Dr, Bountiful, UT 84010-4908 Ph: (801) 299-3781 | Michael S Roundy, PHYSICIAN SURGEON 630 Medical Dr, Bountiful, UT 84010-4908 Ph: (801) 299-3781 |
News Archive
MPI Research announced today that Thomas Laughlin will join the company as Executive Vice President of Sales and Marketing and will be a member of the company's Corporate Management Team. Laughlin's 30+ years of executive experience span several of the world's largest and most successful healthcare products companies.
"A new study suggests that most young gay men in Mexico City would pledge to stay HIV-free, attend a monthly safe-sex talk and take regular HIV tests to prove they were uninfected - all in return for just $288 a year," the New York Times reports.
Traumatic Axonal Injury is a form of traumatic brain injury that can have detrimental effects on the integrity of the brain's white matter and lead to cognitive impairments.
Gilead Sciences says its next generation drug to combat hepatitis C, slated to launch next month, will be more expensive than $1,000-a-pill Sovaldi, in part because the new treatment will be shorter and simpler. Gilead also struck a deal with Indian generic drugmakers to sell lower-cost versions of Sovaldi in poor countries.
Omeros Corporation today announced that its Investigational New Drug Application to evaluate OMS824 in Huntington's disease has been cleared by the U.S. Food and Drug Administration.
› Verified 5 days ago
Patricia F. Voss, PMHNP-BC Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 105 E 800 N, Bountiful, UT 84010 Phone: 801-842-4799 | |
Dr. Oliver Lamont Mcpherson, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 630 Medical Dr, Bountiful, UT 84010 Phone: 801-299-2186 Fax: 801-299-2416 | |
Mohamed Habibulla Sadiq, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 620 East Medical Drive, Suite 150, Bountiful, UT 84010 Phone: 801-298-4112 Fax: 801-298-5397 | |
Dr. Carmela J Javellana, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 13 W 3100 S, Bountiful, UT 84010 Phone: 801-268-0333 Fax: 801-268-3777 | |
Anthony Michael Petersen, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 630 Medical Dr, Bountiful, UT 84010 Phone: 801-299-3781 Fax: 801-299-2416 | |
Kristie Sue Julien, D.O. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 282 Lago Vista Cir, Bountiful, UT 84010 Phone: 801-678-1083 |